Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep 7;4(9):1761-73.
doi: 10.3390/jcm4091761.

Non-Proteinuric Diabetic Nephropathy

Nicolas Roberto Robles  1 , Juan Villa  2 , Roman Hernandez Gallego  3
Affiliations
Review

Non-Proteinuric Diabetic Nephropathy

Nicolas Roberto Robles et al. J Clin Med. .

Abstract

Diabetic nephropathy patients traditionally show significant macroalbuminuria prior to the development of renal impairment. However, this clinical paradigm has recently been questioned. Epidemiological surveys confirm that chronic kidney disease (CKD) diagnosed by a low glomerular filtration rate (GFR) is more common in diabetic patients than in the non-diabetic population but a low number of patients had levels of proteinuria above that which traditionally defines overt diabetic nephropathy (>500 mg/g). The large number of patients with low levels of proteinuria suggests that the traditional clinical paradigm of overt diabetic nephropathy is changing since it does not seem to be the underlying renal lesion in most of diabetic subjects with CKD.

Keywords: chronic kidney disease; diabetes mellitus; microalbuminuria; proteinuria.

PubMed Disclaimer

References

    1. Whiting D., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011;94:311–321. doi: 10.1016/j.diabres.2011.10.029. - DOI - PubMed
    1. De Boer I.H., Rue T.C., Hall Y.N., Heagerty P.J., Weiss N.S., Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532–2539. doi: 10.1001/jama.2011.861. - DOI - PMC - PubMed
    1. Parving H., Lewis J., Ravid M., Remuzzi G., Hunsicker L.G. (DEMAND investigators). Prevalence and risk factors for microalbuminuria in a referred cohort of Type 2 diabetic patients: A global perspective. Kidney Int. 2006;69:2057–2063. doi: 10.1038/sj.ki.5000377. - DOI - PubMed
    1. US Renal Data System . USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD, USA: 2012.
    1. Hill C.J., Fogarty D.G. Changing trends in end-stage renal disease due to diabetes in the United Kingdom. J. Ren. Care. 2012;38(Suppl. 1):12–22. doi: 10.1111/j.1755-6686.2012.00273.x. - DOI - PubMed